This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market
Two adages capture the dilemma investors face when they consider buying a beaten-down stock:
These well-known sayings seem to be contradictory. However, they're not when taken in the correct context. Some sinking stocks have poor underlying businesses and should be avoided -- just like a falling knife. Others have solid underlying businesses and are likely to rebound over time.
I think (NYSE: PFE) falls into the latter category. This S 500 dividend stock could be the best bad-news buy on the market.
Source Fool.com
Pfizer Inc. Stock
€25.68
0.140%
The stock is one of the favorites of our community with 30 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 59.69% compared to the current price of 25.68 € for Pfizer Inc..
